Filter
3196
Filtered Results: 3196
Text search:
Global
Health:
Science
and
Practice
Featured
Recommendations
261
New Publications
719
Language
Document type
No document type
1609
Studies & Reports
764
Guidelines
388
Manuals
192
Strategic & Response Plan
114
Training Material
55
Fact sheets
40
Situation Updates
16
Resource Platforms
8
Infographics
5
Online Courses
3
Brochures
1
App
1
Countries / Regions
Global
159
India
121
Kenya
82
South Africa
76
Africa
66
Sierra Leone
59
Ethiopia
57
Uganda
57
Nigeria
54
Ghana
50
Western and Central Europe
48
Liberia
42
Nepal
41
Malawi
41
Tanzania
40
Latin America and the Carribbean
39
Rwanda
38
Ukraine
28
Syria
27
Eastern Europe
26
Zambia
25
Myanmar / Burma
25
South–East Asia Region
23
Philippines
22
Bangladesh
22
Namibia
21
Guinea
20
Lesotho
20
Congo, Democratic Republic of
19
Russia
18
Zimbabwe
17
Asia
15
Brazil
14
West and Central Africa
14
Senegal
13
Indonesia
13
East and Southern Africa
12
South Sudan
11
Germany
10
Thailand
10
Mozambique
10
Middle East and North Africa
10
Cameroon
9
China
9
Colombia
9
Botswana
9
Burkina Faso
8
Haiti
8
Jordan
8
Cambodia
8
Western Pacific Region
8
Vietnam
8
Eswatini/ Swaziland
7
Mali
6
USA
6
Pakistan
6
Benin
6
Yemen
6
Laos
6
Tajikistan
6
Lebanon
5
Sri Lanka
5
Chile
5
Somalia
4
Sudan
4
Albania
4
Moldova
4
United Kingdom
4
Iraq
3
Turkey
3
Peru
3
Ecuador
3
Eastern Europe and Central Asia
3
Venezuela
3
Southern Africa
3
Kazakhstan
3
Georgia
3
Portugal
3
Spain
3
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Afghanistan
2
Papua New Guinea
2
Central African Republic
2
North Macedonia
2
Angola
2
Canada
2
Romania
2
Kyrgyzstan
2
North America
2
Japan
2
Israel
2
Bosnia and Herzegovina
2
Guinea-Bissau
1
Morocco
1
Chad
1
Gambia
1
Malaysia
1
Argentina
1
Serbia
1
Hungary
1
Burundi
1
Bolivia
1
Greece
1
Libya
1
Madagascar
1
Mexico
1
Paraguay
1
Poland
1
Palestine
1
Armenia
1
Qatar
1
Slovakia
1
Iran
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
957
Clinical Guidelines
238
Public Health
234
Women & Child Health
180
Key Resources
159
Capacity Building
41
Pharmacy & Technologies
36
Toolboxes
Mental Health
277
COVID-19
248
Planetary Health
244
HIV
229
TB
170
AMR
159
Caregiver
125
Disability
117
Global Health Education
94
NCDs
91
Pharmacy
83
Ebola
81
NTDs
74
Rapid Response
70
Conflict
45
Refugee
33
Health Financing Toolbox
29
Social Ethics
28
Natural Hazards
27
Specific Hazards
19
Zika
18
Polio
14
Cholera
9
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals...
This publication outlines public health aspects of alcohol use and harm in WHO South East Asia Region Countries. It summarizes Global Regional ... country specific data and also discusses aspects of alcohol control that are important in the context of the Region. The possible future trend of alcohol use in the Region is also analysed and current and future barriers to effective alcohol control in countries of the Region are discussed.
Journal of Biosocial Science / Volume 34 / Issue 04 / October 2002, pp 525 - 539
DOI: DOI:10.1017/S0021932002005254, Published online: 24 September 2002
This paper examines determinants of one aspect of sexual behaviour – coital frequency –...
This document provides interim guidance for effective risk communication around Zika virus transmission and potential complications. A causal relationship between Zika virus infection and these pote...
Food environments are usually defined as the settings with all the different types of
food made available and accessible to people as they go about their daily lives.
That is, the range of food in supermarkets, small retail outlets, wet markets...
Patient safety assessment manual
recommended
3rd edition. Patient safety standards are critical for the establishment and assessment of patient safety programmes within hospitals. This third edition of the Patient safety assessment manual provides an updated set of standards ... assessment criteria that reflect current best practice and WHO guidance. The manual will support the implementation of patient safety assessments and improvement programmes within hospitals as part of the Patient Safety Friendly Hospital Framework to ensure that patient safety is prioritized and facilities and staff implement best practices. The manual is a key tool for use by professional associations regulatory accrediting or oversight bodies and ministries of health to improve patient safety.
The Africa Centres for Disease Control and Prevention (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (...
In this edition, the Antimicrobial Resistance chapter discusses the growing, dangerous trend of antimicrobial resistance and the potential catastrophic consequences on global ....
Chapter 1 of Frontier 2017: Emerging Issues of Environmental Concern
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- ... middle-income countries, since preparing and storing it require personnel and laboratory infrastructure that are often lacking. An alternative specimen type is dried blood spots (DBS), which can be made without special laboratory processing. DBS are more easily transported than plasma because they can be shipped at ambient temperature as non-hazardous materials using regular mail or courier services.
3rd edition
March 2022. This report on good practices to combat AMR focuses on activities across human, animal, and environmental health in European countries....
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the f...
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions ... recommendations of the fourth international review mission of the Myanmar National TB Programme (NTP), which brought together international and national partners to review progress in TB control and to offer guidance on future TB control directions and efforts.
A high-quality national disease prevalence survey completed in 2010 demonstrated a TB disease burden two to three times higher than anticipated on the basis of previous surveys. In 2011 about 200 000 adults and children will have developed TB, including 20 000 HIV infected and 9000 suffering from MDR-TB, both of which will require additional care and costly treatment. TB remains among the top killers of adults, and more women die of TB than from maternal causes.
A high-quality national disease prevalence survey completed in 2010 demonstrated a TB disease burden two to three times higher than anticipated on the basis of previous surveys. In 2011 about 200 000 adults and children will have developed TB, including 20 000 HIV infected and 9000 suffering from MDR-TB, both of which will require additional care and costly treatment. TB remains among the top killers of adults, and more women die of TB than from maternal causes.
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The ... baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele and over 15 million people with lymphoedema. At least 36 million persons remain with these chronic disease manifestations. The disease is endemic in 72 countries. In 2016, an estimated total population of 856 million were living in areas with ongoing transmission of the causative filarial parasites and requiring mass drug administration (MDA). Lymphatic filariasis disfigures and disables, and often leads to stigmatization and poverty. Hundreds of millions of dollars are lost annually due to reduced productivity of affected patients. WHO has ranked the disease as one of the world’s leading causes of permanent and long-term disability.
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of public hea... care. The Standards identify major components and features of effective systems for the treatment of drug use disorders. They describe treatment modalities and interventions to match the needs of people at different stages and severities of drug use disorders, in a manner consistent with the treatment of any chronic disease or health condition. The Standards are aspirational, and such, national or local treatment services or systems need not attempt to meet all the standards and recommendations made in this document all at once. However over time, progressive quality improvement, with ‘evidence-based and ethical practice’ as an objective, can and should be expected to achieve better organized, more effective and ethical systems and services for people with drug use disorders.
This document presents a strategic framework, aimed towards the development of sustainable global, regional and national plans relating to laboratory biorisk management.
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (E...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral gl... action plan on epilepsy and other neurological disorders 2022–2031.
The technical brief presents the key information on epilepsy and recommends actions to policy makers and other stakeholders. Using the concept of levers for change introduced by the Operational Framework for Primary Health Care, it identifies actions on the policy and operational levels that stakeholders should take to strengthen services for people with epilepsy using a person-centered approach based on human rights and universal health coverage.
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent C...
This brief focuses specifically on the Grand Nord (Great North): the Beni and Lubero territories of northern North Kivu that are the epicentre of the outbreak. Further participatory enquiry should be undertaken with the affected populations, but giv...
Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the ... PPS project from University of Antwerp, the US Centers for Disease Control and Prevention (CDC), and the Medicines Utilisation Research in Africa (MURIA).
Point Prevalence Surveys collects information on prescribing practices of antibiotics and other information relevant to treatment and management of infectious diseases in hospitalized patients, and complements surveillance of antimicrobial consumption.
